INTRODUCTION: Myocardial infarction (MI) is associated with an increase in subsequent heart failure (HF), recurrent ischemic events, sudden cardiac arrest, and ventricular arrhythmias (SCA-VA). The primary objective of the study to determine the role of intercurrent HF and ischemic events on the development of SCA-VA following first type I MI. METHODS AND RESULTS: A retrospective cohort study of patients experiencing first type 1 MI in Olmsted County, Minnesota (2002-2012) was conducted by identifying patients using the medical records linkage system (Rochester epidemiology project). Patients aged ≥18 years were followed from the time of MI till death or 31 July, 2017. Intercurrent HF and ischemic events were the primary exposures following MI and their association with outcome SCA-VA was assessed. Eight hundred and sixty-seven patients (mean age was 63 ± 14.5 years; 69% male; 49.8% ST-elevation myocardial infarction) who had their first type I MI during the study period were included. Majority of acute MI patients were revascularized using percutaneous coronary intervention and bypass surgery (628 [72.43%] and 87 [10.03%] respectively). During a mean follow-up of 7.69 ± 4.17 years, HF, recurrent ischemic events and SCA-VA occurred in 155 (17.9%), 245 (28.3%), and 40 (4.61%) patients respectively. Low ejection fraction (adjusted hazard ratio [HR] 0.95; 95% confidence interval [CI], 0.93-0.98; P < .001), intercurrent HF (adjusted HR 3.11; 95% CI, 1.39-6.95; P = .006) and recurrent ischemic events (adjusted HR 3.47; 95% CI, 1.68-7.18; P < .001) were associated with subsequent SCA-VA. CONCLUSION: SCA-VA occurred in a small proportion of patients after MI and is associated with intercurrent HF and recurrent ischemic events.
INTRODUCTION:Myocardial infarction (MI) is associated with an increase in subsequent heart failure (HF), recurrent ischemic events, sudden cardiac arrest, and ventricular arrhythmias (SCA-VA). The primary objective of the study to determine the role of intercurrent HF and ischemic events on the development of SCA-VA following first type I MI. METHODS AND RESULTS: A retrospective cohort study of patients experiencing first type 1 MI in Olmsted County, Minnesota (2002-2012) was conducted by identifying patients using the medical records linkage system (Rochester epidemiology project). Patients aged ≥18 years were followed from the time of MI till death or 31 July, 2017. Intercurrent HF and ischemic events were the primary exposures following MI and their association with outcome SCA-VA was assessed. Eight hundred and sixty-seven patients (mean age was 63 ± 14.5 years; 69% male; 49.8% ST-elevation myocardial infarction) who had their first type I MI during the study period were included. Majority of acute MI patients were revascularized using percutaneous coronary intervention and bypass surgery (628 [72.43%] and 87 [10.03%] respectively). During a mean follow-up of 7.69 ± 4.17 years, HF, recurrent ischemic events and SCA-VA occurred in 155 (17.9%), 245 (28.3%), and 40 (4.61%) patients respectively. Low ejection fraction (adjusted hazard ratio [HR] 0.95; 95% confidence interval [CI], 0.93-0.98; P < .001), intercurrent HF (adjusted HR 3.11; 95% CI, 1.39-6.95; P = .006) and recurrent ischemic events (adjusted HR 3.47; 95% CI, 1.68-7.18; P < .001) were associated with subsequent SCA-VA. CONCLUSION: SCA-VA occurred in a small proportion of patients after MI and is associated with intercurrent HF and recurrent ischemic events.
Authors: Wayne D Rosamond; Lloyd E Chambless; Gerardo Heiss; Thomas H Mosley; Josef Coresh; Eric Whitsel; Lynne Wagenknecht; Hanyu Ni; Aaron R Folsom Journal: Circulation Date: 2012-03-15 Impact factor: 29.690
Authors: Ezra A Amsterdam; Nanette K Wenger; Ralph G Brindis; Donald E Casey; Theodore G Ganiats; David R Holmes; Allan S Jaffe; Hani Jneid; Rosemary F Kelly; Michael C Kontos; Glenn N Levine; Philip R Liebson; Debabrata Mukherjee; Eric D Peterson; Marc S Sabatine; Richard W Smalling; Susan J Zieman Journal: J Am Coll Cardiol Date: 2014-09-23 Impact factor: 24.094
Authors: Romolo Gaspari; Anthony Weekes; Srikar Adhikari; Vicki Noble; Jason T Nomura; Daniel Theodoro; Michael Woo; Paul Atkinson; David Blehar; Samuel Brown; Terrell Caffery; Emily Douglass; Jacqueline Fraser; Christine Haines; Samuel Lam; Michael Lanspa; Margaret Lewis; Otto Liebmann; Alexander Limkakeng; Fernando Lopez; Elke Platz; Michelle Mendoza; Hal Minnigan; Christopher Moore; Joseph Novik; Louise Rang; Will Scruggs; Christopher Raio Journal: Resuscitation Date: 2017-09-13 Impact factor: 5.262
Authors: Wassim H Fares; Sarah K Blanchard; George A Stouffer; Patricia P Chang; Wayne D Rosamond; Hubert James Ford; Robert M Aris Journal: Can Respir J Date: 2012 Jul-Aug Impact factor: 2.409
Authors: Fred M Kusumoto; Kent R Bailey; Ahmad Sami Chaouki; Abhishek J Deshmukh; Sandeep Gautam; Robert J Kim; Daniel B Kramer; Litsa K Lambrakos; Naseer H Nasser; Dan Sorajja Journal: J Am Coll Cardiol Date: 2017-10-30 Impact factor: 24.094
Authors: Sheila M Manemann; Yariv Gerber; Alanna M Chamberlain; Shannon M Dunlay; Malcolm R Bell; Allan S Jaffe; Susan A Weston; Jill M Killian; Jan Kors; Véronique L Roger Journal: Mayo Clin Proc Date: 2015-03-18 Impact factor: 7.616
Authors: Richard D Hurt; Susan A Weston; Jon O Ebbert; Sheila M McNallan; Ivana T Croghan; Darrell R Schroeder; Véronique L Roger Journal: Arch Intern Med Date: 2012-11-26
Authors: Maan Jokhadar; Steven J Jacobsen; Guy S Reeder; Susan A Weston; Véronique L Roger Journal: Am J Epidemiol Date: 2004-06-01 Impact factor: 4.897
Authors: Walter A Rocca; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; L Joseph Melton Journal: Mayo Clin Proc Date: 2012-11-28 Impact factor: 7.616